As CEO and co-Founder of Ventrix, Inc., we are working to commercialize novel injectable biomaterials for tissue repair and cardiovascular repair. At Ventrix, I have led the team to raising a Series A financing and pushing the product from concept to the clinic. Prior to my time at Ventrix, I nurtured and launched early-stage biotechnology startups and performed due diligence for venture capital. I have a Ph.D. and a certificate in Management of Technology from UC Berkeley.